Global Clot Management DevicesMarket Regional Analysis
North America is expected to holda dominant position in the global ClotManagement Devices Market over the forecast period, owing to frequentresearch and development activities in the region.
For instance, in April 2019,Tufts Medical Center in Boston and Eskenazi Health, a partner with the IndianaUniversity School of Medicine, are developing a Mobile Active Compression (MAC)calf device for prevention of deep vein thrombosis. MAC is light-weight andportable device, which can be worn around limbs, as limbs have higher risk ofdeep vein thrombosis. Such innovations associated with clot management devicesare expected to accelerate the global clot management devices market growth.
Blood clot is usually a responseto the injury so as to prevent infection and minimize the blood flow. Embolusis a part of blood-clotting, which separates from the site of thrombus andcirculate through bloodstream into the body. It can obstruct the function ofblood vessels and thus leading to harmful effects in the body. Highcholesterol, heavy weight of body, diabetes, cancer, and sedentary lifestylecan be a cause for clotting of blood in the body. These blood clots can betreated by medications such as anti-coagulants, compression stockings, surgery,stents, and vena cava filter. These treatments prevent from formation of moreblood clots in the body.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2650
Global Clot Management DevicesMarket Drivers
Approval and launch of the novelclot management devices are expected to boost the global clot managementdevices market. For instance, in May 2019, the U.S. Food and DrugAdministration (FDA) approved Bashir Endovascular Catheter (BEC) and Bashir N-Xendovascular catheter (BEC N-X) developed by a scientist from Temple UniversityHospital in Philadelphia, Pennsylvania and is being commercialized byThrombolex, Inc. BEC received approval for its controlled infusion of fluids(thrombolytics) in peripheral vasculature and BEC N-X is being used forcontrolled infusion of fluids into pulmonary and peripheral vasculature.
Furthermore, key players are alsotrying to expand the indications of its already approved products. Forinstance, in February 2018, the U.S. FDA expanded indications for Trevo clotretriever, a device designed by Stryker Corporations. Trevo Retriever is thefirst thrombectomy device to receive approval for expansion by 18 hours oftreatment time for acute ischemic stroke. Originally Trevo clot retriever hadbeen approved in 2012. Such frequent approvals by the U.S. FDA is expected todrive the global clot management device market growth.
Furthermore, activities such ascollaborations, partnerships, merger, and acquisitions of the manufacturers areexpected to drive the global clot management devices market growth. Forinstance, in September 2018, LeMaitre Vascular Corporation acquired vascularclot management business of Applied Medical Resources Corporation. The partieshad undergone an agreement of transitional services, where Applied MedicalResources Corporation was supposed to manufacture its clot management productline for LeMaitre Vascular Corporation. This factor is expected to have apositive influence on the global clot management devices market growth over theforecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/clot-management-devices-market-2650
Global Clot Management DevicesMarket Restraints
High cost of clot managementdevices is expected to hamper the global clot management devices market growthover the forecast period. For instance, according to the data published byNational Center for Biotechnology Information (NCBI) in 2016, the cost of 5MAXACE catheter, used for the extraction of clots in ischemic stroke was aroundUS$ 4,916. Hence, high cost may lead to lesser adoption of devices and thereby,hindering the global clot management devices market growth.
Global Clot Management DevicesMarket Key Players
Some of the major playersoperating in the global clot management devices market include EdwardLifesciences Corporation, Straub Medical AG, Boston Scientific Corporation,Medtronic, Inc., Volcano Corporation, LeMaitre Vascular, Inc., Teleflex Inc.,Argon Medical, Stryker Corporation, and Angiodynamics.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2650
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
